Summit Global Investments Lowers Holdings in Colgate-Palmolive Company $CL

15 Aug 2026, 13:04 by Kim Johansen · The Markets Daily

Summit Global Investments decreased its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 6.6% during the second quarter, HoldingsChannel.com reports. The firm owned 103,583 shares of the company’s stock after selling 7,369 shares during the quarter. Colgate-Palmolive makes up approximately 0.5% of Summit Global Investments’ holdings, making the stock its 17th largest holding. Summit Global Investments’ holdings in Colgate-Palmolive were worth $9,496,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Pinnacle Associates Ltd. increased its stake in Colgate-Palmolive by 1.5% during the 2nd quarter. Pinnacle Associates Ltd. now owns 70,095 shares of the company’s stock valued at $6,426,000 after purchasing an additional 1,007 shares in the last quarter. Smith Shellnut Wilson LLC ADV bought a new position in shares of Colgate-Palmolive in the second quarter worth approximately $211,000. Bryn Mawr Trust Advisors LLC grew its holdings in shares of Colgate-Palmolive by 5.6% during the second quarter. Bryn Mawr Trust Advisors LLC now owns 3,354 shares of the company’s stock valued at $308,000 after buying an additional 177 shares during the last quarter. Massachusetts Wealth Management grew its holdings in shares of Colgate-Palmolive by 2.1% during the second quarter. Massachusetts Wealth Management now owns 13,478 shares of the company’s stock valued at $1,236,000 after buying an additional 275 shares during the last quarter. Finally, Oppenheimer & Co. Inc. raised its holdings in Colgate-Palmolive by 0.4% in the 2nd quarter. Oppenheimer & Co. Inc. now owns 54,445 shares of the company’s stock worth $4,992,000 after acquiring an additional 236 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. Piper Sandler increased their target price on Colgate-Palmolive from $92.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Sanford C. Bernstein restated a “market perform” rating on shares of Colgate-Palmolive in a research note on Thursday. Wells Fargo & Company upped their price target on Colgate-Palmolive from $92.00 to $95.00 and gave the company an “equal weight” rating in a report on Wednesday, July 8th. TD Cowen increased their price objective on Colgate-Palmolive from $85.00 to $90.00 and gave the company a “hold” rating in a research report on Monday, August 3rd. Finally, Royal Bank Of Canada lifted their price objective on Colgate-Palmolive from $102.00 to $104.00 and gave the stock an “outperform” rating in a report on Monday, August 3rd. Twelve equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $99.00.

Get Our Latest Stock Analysis on CL

Insiders Place Their Bets

In related news, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the transaction, the director owned 28,373 shares in the company, valued at approximately $2,649,187.01. The trade was a 12.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Noel R. Wallace sold 161,021 shares of the stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total value of $14,801,050.32. Following the completion of the sale, the chief executive officer owned 362,231 shares of the company’s stock, valued at $33,296,273.52. The trade was a 30.77% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.43% of the stock is currently owned by insiders.

Colgate-Palmolive Trading Down 1.1%

Shares of NYSE:CL opened at $91.90 on Friday. The stock has a 50 day moving average of $91.67 and a 200 day moving average of $89.99. The company has a market cap of $73.26 billion, a PE ratio of 36.47, a price-to-earnings-growth ratio of 4.54 and a beta of 0.33. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82.

Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company had revenue of $5.36 billion for the quarter, compared to analysts’ expectations of $5.36 billion. During the same quarter last year, the business earned $0.92 EPS. The firm’s revenue was up 4.9% compared to the same quarter last year. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.86 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Monday, July 20th were given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. The ex-dividend date was Monday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 84.13%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.